{"timestamp": 1771602769.034357, "value": {"ticker": "NBY", "company_name": "NovaBay Pharmaceuticals, Inc.", "short_name": "NovaBay Pharmaceuticals, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 80577768, "float_shares": 10242154, "shares_outstanding": 129608757, "short_ratio": 1.19, "short_percent_of_float": 0.0216, "shares_short": 2701762, "shares_short_prior": 1361975, "insider_percent_held": 0.91872, "institution_percent_held": 0.05455, "total_cash": 2309000, "total_debt": 970000, "total_revenue": 10302000, "revenue_growth": -0.787, "earnings_growth": 0, "profit_margins": 0.31479, "gross_margins": 0.63318, "operating_margins": -2.24376, "debt_to_equity": 59.364, "current_ratio": 2.001, "book_value": -0.446, "price_to_book": -1.3939462, "operating_cashflow": 2957000, "free_cashflow": -2638125, "price": 0.6217, "52w_high": 19.95, "52w_low": 0.46, "avg_volume": 1923168, "avg_volume_10d": 1691350, "full_time_employees": 13, "audit_risk": 0, "overall_risk": 0}}